Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer

Our objective was to evaluate thyroid nodule malignancy prediction using thyroid function tests, autoantibodies, ultrasonographic imaging, and clinical data. We conducted a retrospective cohort study in 1400 patients with nodular thyroid disease (NTD). The thyroid stimulating hormone (TSH) concentra...

Full description

Saved in:
Bibliographic Details
Main Authors: Lin-zheng He, Tian-shu Zeng, Lin Pu, Shi-xiu Pan, Wen-fang Xia, Lu-lu Chen
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2016/8215834
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849415314523029504
author Lin-zheng He
Tian-shu Zeng
Lin Pu
Shi-xiu Pan
Wen-fang Xia
Lu-lu Chen
author_facet Lin-zheng He
Tian-shu Zeng
Lin Pu
Shi-xiu Pan
Wen-fang Xia
Lu-lu Chen
author_sort Lin-zheng He
collection DOAJ
description Our objective was to evaluate thyroid nodule malignancy prediction using thyroid function tests, autoantibodies, ultrasonographic imaging, and clinical data. We conducted a retrospective cohort study in 1400 patients with nodular thyroid disease (NTD). The thyroid stimulating hormone (TSH) concentration was significantly higher in patients with differentiated thyroid cancer (DTC) versus benign thyroid nodular disease (BTND) (p=0.004). The receiver operating characteristic curve of TSH showed an AUC of 0.58 (95% CI 0.53–0.62, p=0.001), sensitivity of 74%, and specificity of 57% at a cut-off of 1.59 mIU/L. There was an incremental increase in TSH concentration along with the increasing tumor size (p<0.001). Thyroglobulin antibody (TgAb) concentration was associated with an increased risk of malignancy (p=0.029), but this association was lost when the effect of TSH was taken into account (p=0.11). Thyroid ultrasonographic characteristics, including fewer than three nodules, hypoechoic appearance, solid component, poorly defined margin, intranodular or peripheral-intranodular flow, and punctate calcification, can be used to predict the risk of thyroid cancer. In conclusion, our study suggests that preoperative serum TSH concentration, age, and ultrasonographic features can be used to predict the risk of malignancy in patients with NTD.
format Article
id doaj-art-572ac0c5be6040b0a00c4e9a9f4fca73
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-572ac0c5be6040b0a00c4e9a9f4fca732025-08-20T03:33:34ZengWileyInternational Journal of Endocrinology1687-83371687-83452016-01-01201610.1155/2016/82158348215834Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid CancerLin-zheng He0Tian-shu Zeng1Lin Pu2Shi-xiu Pan3Wen-fang Xia4Lu-lu Chen5Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Endocrinology, Chengdu First People’s Hospital, Chengdu 610041, ChinaDepartment of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaOur objective was to evaluate thyroid nodule malignancy prediction using thyroid function tests, autoantibodies, ultrasonographic imaging, and clinical data. We conducted a retrospective cohort study in 1400 patients with nodular thyroid disease (NTD). The thyroid stimulating hormone (TSH) concentration was significantly higher in patients with differentiated thyroid cancer (DTC) versus benign thyroid nodular disease (BTND) (p=0.004). The receiver operating characteristic curve of TSH showed an AUC of 0.58 (95% CI 0.53–0.62, p=0.001), sensitivity of 74%, and specificity of 57% at a cut-off of 1.59 mIU/L. There was an incremental increase in TSH concentration along with the increasing tumor size (p<0.001). Thyroglobulin antibody (TgAb) concentration was associated with an increased risk of malignancy (p=0.029), but this association was lost when the effect of TSH was taken into account (p=0.11). Thyroid ultrasonographic characteristics, including fewer than three nodules, hypoechoic appearance, solid component, poorly defined margin, intranodular or peripheral-intranodular flow, and punctate calcification, can be used to predict the risk of thyroid cancer. In conclusion, our study suggests that preoperative serum TSH concentration, age, and ultrasonographic features can be used to predict the risk of malignancy in patients with NTD.http://dx.doi.org/10.1155/2016/8215834
spellingShingle Lin-zheng He
Tian-shu Zeng
Lin Pu
Shi-xiu Pan
Wen-fang Xia
Lu-lu Chen
Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer
International Journal of Endocrinology
title Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer
title_full Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer
title_fullStr Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer
title_full_unstemmed Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer
title_short Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer
title_sort thyroid hormones autoantibodies ultrasonography and clinical parameters for predicting thyroid cancer
url http://dx.doi.org/10.1155/2016/8215834
work_keys_str_mv AT linzhenghe thyroidhormonesautoantibodiesultrasonographyandclinicalparametersforpredictingthyroidcancer
AT tianshuzeng thyroidhormonesautoantibodiesultrasonographyandclinicalparametersforpredictingthyroidcancer
AT linpu thyroidhormonesautoantibodiesultrasonographyandclinicalparametersforpredictingthyroidcancer
AT shixiupan thyroidhormonesautoantibodiesultrasonographyandclinicalparametersforpredictingthyroidcancer
AT wenfangxia thyroidhormonesautoantibodiesultrasonographyandclinicalparametersforpredictingthyroidcancer
AT luluchen thyroidhormonesautoantibodiesultrasonographyandclinicalparametersforpredictingthyroidcancer